{"id":167264,"date":"2025-03-07T05:14:18","date_gmt":"2025-03-07T10:14:18","guid":{"rendered":"https:\/\/44.250.171.167\/?p=167264"},"modified":"2025-03-07T05:14:18","modified_gmt":"2025-03-07T10:14:18","slug":"pfizer-ltd-q3fy25-2-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/pfizer-ltd-q3fy25-2-fall-in-profits\/","title":{"rendered":"Pfizer Ltd Q3FY25; 2% fall in Profits"},"content":{"rendered":"<p>Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract\/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.<\/p>\n<h2>\nFinancial Results:<\/h2>\n<p>Pfizer Ltd reported Revenues for Q3FY25 of \u20b9538.00 Crores down from \u20b9540.00 Crore year on year, a fall of 0.37%.<\/p>\n<p>Total Expenses for Q3FY25 of \u20b9409.00 Crores up from \u20b9408.00 Crores year on year, a rise of 0.25%.<\/p>\n<p>Consolidated Net Profit of \u20b9128.00 Crores down 1.54% from \u20b9130.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b927.89, down 1.83% from \u20b928.41 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-167265\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/3-4-839x1024.png\" alt=\"\" width=\"640\" height=\"781\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/3-4-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/3-4-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/3-4-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/3-4-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/3-4.png 1489w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract\/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India. Financial Results: [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":167265,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[11776,11950,10162],"class_list":["post-167264","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-active-pharmaceutical-ingredients","tag-medicine","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/3-4.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":166980,"url":"https:\/\/alphastreet.com\/india\/abbott-india-ltd-q3fy25-88-fall-in-profits\/","url_meta":{"origin":167264,"position":0},"title":"Abbott India Ltd Q3FY25; 88% fall in Profits","author":"Divyansh_Kasana","date":"February 19, 2025","format":false,"excerpt":"Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944. Financial Results: Abbott India Ltd reported Revenues for Q3FY25 of \u20b922,848.00 Crores down from \u20b925,050.00 Crore year on year, a fall of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166823,"url":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q3fy25-6-fall-in-profits\/","url_meta":{"origin":167264,"position":1},"title":"Granules India Ltd Q3FY25; 6% fall in Profits","author":"Divyansh_Kasana","date":"February 12, 2025","format":false,"excerpt":"Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q3FY25 of \u20b91,138.00 Crores down from \u20b91,156.00 Crore year on year, a fall of 1.56%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167470,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-ltd-q3fy25-34-fall-in-profits\/","url_meta":{"origin":167264,"position":2},"title":"Sanofi India Ltd Q3FY25; 34% fall in Profits","author":"Chirag Gupta","date":"March 19, 2025","format":false,"excerpt":"Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines. Financial Results: Sanofi India Ltd reported Revenues for Q3FY25 of \u20b9515.00 Crores up from \u20b9469.00 Crore\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167105,"url":"https:\/\/alphastreet.com\/india\/astrazeneca-pharma-india-ltd-q3fy25-69-fall-in-profits\/","url_meta":{"origin":167264,"position":3},"title":"Astrazeneca Pharma India Ltd Q3FY25; 69% fall in Profits","author":"Divyansh_Kasana","date":"February 27, 2025","format":false,"excerpt":"AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India Ltd reported Revenues for Q3FY25 of \u20b91,050.00 Crores up from \u20b9955.00 Crore year on year, a rise of 9.95%. Total Expenses for Q3FY25 of \u20b9957.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/T.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/T.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/T.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/T.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/T.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/T.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167647,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q3fy25-14-fall-in-profits\/","url_meta":{"origin":167264,"position":4},"title":"ERIS Lifesciences Ltd Q3FY25; 14% fall in Profits","author":"Divyansh_Kasana","date":"March 31, 2025","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q3FY25 of \u20b9727.00 Crores up from \u20b9486.00 Crore year on year, a rise of 49.59%. Total Expenses for Q3FY25 of \u20b9615.00 Crores up from \u20b9375.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166509,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q3fy25-14-rise-in-profits\/","url_meta":{"origin":167264,"position":5},"title":"Torrent Pharmaceuticals Ltd Q3FY25; 14% rise in Profits","author":"Chirag Gupta","date":"January 24, 2025","format":false,"excerpt":"Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b92,809.00 Crores up from \u20b92,732.00 Crore year on year, a rise of 2.82%. Total Expenses for Q3FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=167264"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167264\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/167265"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=167264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=167264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=167264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}